LightMD’s Unique Phototherapy System
Based on over a decade of case studies and engineering developments, the ABP1003 Phototherapy System available in the USA exclusively from LightMD represents the state-of-the-art in medical-grade phototherapy. Each system comprises a touch-screen based “LightMachine” central controller and two sets of 3D-bendable flexible hypoallergenic polymeric LightPads, with each of the six LightPads containing hundreds of super-luminous (i.e. high-brightness) red and infrared LEDs. In use, the snug fit offered by its bendable LightPads to the human torso and appendages insures superior energy coupling into affected tissue with minimal unwanted reflections or scattering. Each LightPad is driven in a programmed sequence or “treatment” (typically lasting 20 minutes) comprising alternating intervals of red and infrared light (to control penetration depth) pulsed at prescribed rates to maximize energy coupling to specific tissue types. Treatments, in turn, are organized into sequences called “protocols” to insure pain, inflammation, and infection are combatted systematically to speed recovery.
LEDs are driven at their maximum possible brightness to insure treatment efficacy yet to avoid burn risk and insure photobiological safety (a safety level lasers cannot guarantee). Moreover, based on a decade of exhaustive case studies, the importance of LED pulse frequency rates and the system’s versatile control of these pulse rates cannot be overstated. For example, high frequency pulsed operation reduces pain by controlling signal transduction throughout the nervous system while lower frequencies are used to stimulate the release of nitrous oxide (NO) thereby improving vasodilation and tissue oxygenation.
As a class II device, the light therapy offered by LightMD is based on FDA audited and approved technology now authorized for use in the USA, in Taiwan, in Dubai, and across the United Arab Emirates (UAE) with more countries coming soon. In addition to its global medical, safety and GMP (good manufacturing practices) certifications, the device is also protected by numerous claims granted by the United States Patent & Trademark Office (US PTO) to its FDA approved manufacturing business partner Applied BioPhotonics Ltd.
Dan Schell, President and Inventor, LightMD
LightMD’s Unique Phototherapy System
